SGX943 FDA Approval Status
FDA Approved: No
Brand name: SGX943
Generic name: dusquetide
Company: Soligenix, Inc.
Treatment for: Melioidosis
SGX943 (dusquetide) is an Innate Defense Regulator (IDR) in development for the treatment of melioidosis.
Development timeline for SGX943
| Date | Article |
|---|---|
| May 31, 2016 | FDA Grants Soligenix “Fast Track” Designation for SGX943 for the Treatment of Melioidosis |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
